| Secondary |
| Drug Use For Unknown Indication |
30.1% |
| Product Used For Unknown Indication |
21.1% |
| Hypertension |
10.5% |
| Cardiac Failure |
6.0% |
| Coronary Artery Disease |
5.3% |
| Antiinflammatory Therapy |
3.8% |
| Type Ii Diabetes Mellitus |
3.8% |
| Essential Hypertension |
3.0% |
| Analgesic Therapy |
2.3% |
| Diabetes Mellitus |
2.3% |
| Drug Therapy |
2.3% |
| Metastases To Bone |
2.3% |
| Osteomyelitis Chronic |
1.5% |
| Parkinson's Disease |
1.5% |
| Adverse Event |
0.8% |
| Alopecia |
0.8% |
| Antiplatelet Therapy |
0.8% |
| Back Disorder |
0.8% |
| Delivery |
0.8% |
| Diabetes Mellitus Management |
0.8% |
|
| Completed Suicide |
8.5% |
| Renal Impairment |
8.5% |
| Bradycardia |
6.4% |
| Death |
6.4% |
| Hyperkalaemia |
6.4% |
| Mesenteric Occlusion |
6.4% |
| Poisoning |
6.4% |
| Tumour Lysis Syndrome |
6.4% |
| Angioedema |
4.3% |
| Blood Urea Increased |
4.3% |
| Chest Pain |
4.3% |
| Renal Failure |
4.3% |
| Renal Failure Acute |
4.3% |
| Syncope |
4.3% |
| Tremor |
4.3% |
| Vertigo |
4.3% |
| Vomiting |
4.3% |
| Blood Creatinine Increased |
2.1% |
| Cardiac Failure Congestive |
2.1% |
| Drug Hypersensitivity |
2.1% |
|
| Concomitant |
| Hypertension |
28.9% |
| Product Used For Unknown Indication |
26.2% |
| Type 2 Diabetes Mellitus |
8.3% |
| Drug Use For Unknown Indication |
6.3% |
| Diabetes Mellitus |
6.2% |
| Peritoneal Dialysis |
2.8% |
| Acute Myocardial Infarction |
2.6% |
| Colitis Ulcerative |
2.3% |
| Coronary Artery Disease |
2.1% |
| Depression |
1.6% |
| Fibromyalgia |
1.6% |
| Hyperlipidaemia |
1.6% |
| Cardiac Failure |
1.5% |
| Atrial Fibrillation |
1.3% |
| Pain |
1.3% |
| Prophylaxis |
1.3% |
| Colorectal Cancer Metastatic |
1.2% |
| Contraception |
1.0% |
| Rheumatoid Arthritis |
0.9% |
| Cardiac Failure Chronic |
0.8% |
|
| Weight Decreased |
13.0% |
| Renal Failure |
9.7% |
| Renal Failure Acute |
8.1% |
| Death |
6.9% |
| Vomiting |
6.9% |
| Pyrexia |
5.7% |
| Hypertension |
5.3% |
| Dyspnoea |
4.5% |
| Pancreatitis |
4.5% |
| Myocardial Infarction |
4.0% |
| Coronary Artery Stenosis |
3.6% |
| Glycosylated Haemoglobin Increased |
3.6% |
| Hypotension |
3.6% |
| Pancreatitis Acute |
3.2% |
| Stent Placement |
3.2% |
| Syncope |
3.2% |
| Cardiac Failure Congestive |
2.8% |
| Hyperkalaemia |
2.8% |
| Vascular Graft |
2.8% |
| Blood Creatinine Increased |
2.4% |
|
| Interacting |
|
| Hyperkalaemia |
50.0% |
| Drug Interaction |
25.0% |
| Hyponatraemia |
25.0% |
|
